article thumbnail

The Codon Guide to Synthetic Biology

Codon

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). Synthesis.cc (2022).

DNA 98
article thumbnail

Biologics and living drugs: entering a new era of cancer treatment

Drug Discovery World

This paid-for advertorial by Sphere Fluidics appeared in the SLAS 2023 Supplement, Volume 24 – Issue 1, Winter 2022/2023 Modern drug development has expanded from chemist-made substances to biologics and cell-based therapies.

Treatment 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

#ScienceSaturday: March 2, 2024

KIF1A

Wendy Chung discusses advances from the Simons Foundation Powering Autism Research for Knowledge (SPARK) Project, which enrolled 275,000 participants with and without autism, between 2016 and 2022. This has created a platform to learn about autism-associated genes, identify risk factors for subgroups, and better inform new interventions.

article thumbnail

Condensate biology: advancing drug discovery for complex diseases

Drug Target Review

The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.

Disease 98
article thumbnail

The Codon Guide to Synthetic Biology

Codon

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). Synthesis.cc (2022).

DNA 52
article thumbnail

A T cell receptor immunotherapy against a novel target

Drug Target Review

Can you explain the mechanism of action by which ImmTAC molecules selectively target and kill cancer cells? She has deep knowledge in Immunology and T cell biology, and 13 years of experience in Research (seven of them in biotech at Immunocore), including pipeline programme leadership.

article thumbnail

Avoiding detection – the cancer cells evading the body’s natural defence

Drug Discovery World

Senior author Marcia Haigis, Professor of cell biology in the Blavatnik Institute at Harvard Medical School has been working in this area for 15 years. With further research, the team at Harvard Medical School hope that more targeted therapies can be developed to treat cancers whose growth is fuelled by this metabolite. Haigis asks.